{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BXN.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BXN.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","market":"AU","secType":"STK","nameCN":"BIOXYNE LTD","latestPrice":0.03,"timestamp":1741147495253,"preClose":0.027,"halted":0,"volume":1804415,"delay":0,"changeRate":0.111111,"change":0.003,"floatShares":397653450,"shares":2049228732,"eps":-0.006903,"lyrEps":-0.006903,"pbRate":17.05,"amount":51579,"amplitude":0.074074,"volumeRatio":0.621529,"dividePrice":0,"prevYearClose":0.027,"fiveDayClose":0.027,"twentyDayClose":0.039},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","floatShares":397653450,"roa":"-5.81%","roe":"-141.76%","lyrEps":-0.006903,"volumeRatio":0.621529,"shares":2049228732,"dividePrice":0,"high":0.03,"amplitude":0.074074,"preClose":0.027,"low":0.028,"week52Low":0.004,"pbRate":"17.05","psRate":"6.38","week52High":0.053,"institutionHeld":0,"latestPrice":0.03,"committee":0.674613,"eps":-0.006903,"divideRate":0,"volume":1804415,"delay":0,"ttmEps":-0.006903,"open":0.028,"prevYearClose":0.027,"prevWeekClose":0.03,"prevMonthClose":0.03,"prevQuarterClose":0.027,"fiveDayClose":0.027,"twentyDayClose":0.039,"sixtyDayClose":0.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BXN.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BXN.AU\",market:\"AU\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BXN.AU\",params:#limit:6,delay:false,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.003276}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BXN.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508925319","title":"Shareholders have faith in loss-making Bioxyne (ASX:BXN) as stock climbs 47% in past week, taking one-year gain to 267%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508925319","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508925319?lang=en_us&edition=fundamental","pubTime":"2025-02-01 04:17","pubTimestamp":1738354622,"startTime":"0","endTime":"0","summary":"Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really flourishing, you can make more than 100%. For example, the Bioxyne Limited  share price has soared 267% in the last 1 year. Most would be very happy with that, especially in just one year!Shareholders are also celebrating an even better 267% rise, over the last three months. And shareholders have also done well over the long term, with an increase of 110% in the last three years.The past week has proven to be lucrative for Bioxyne investors, so let's see if fundamentals drove the company's one-year performance.Bioxyne grew its revenue by 82% last year. That's well above most other pre-profit companies. Meanwhile, the market has paid attention, sending the share price soaring 267% in response. That sort of revenue growth is bound to attract attention, even if the company doesn't turn a profit. Given the positive sentiment around the stock we're cautious, but there's no doubt ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shareholders-faith-loss-making-bioxyne-201702389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7111","BK7508","BXN.AU"],"gpt_icon":0},{"id":"2506536229","title":"Corrected-Bioxyne Ltd - a$8.1 Mln (Not a$6.1 Mln) Q2 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2506536229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506536229?lang=en_us&edition=fundamental","pubTime":"2025-01-28 07:02","pubTimestamp":1738018950,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL5N3ON21D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BXN.AU","BK7508","BK7111"],"gpt_icon":0},{"id":"2506536015","title":"BRIEF-Bioxyne Posts A$8.1 Mln Q2 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2506536015","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506536015?lang=en_us&edition=fundamental","pubTime":"2025-01-28 07:02","pubTimestamp":1738018950,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Posts A$8.1 Mln Q2 RevenueJan 28 (Reuters) - Bioxyne Ltd BXN.AX:A$8.1 MILLION (NOT A$6.1 MILLION) Q2 REVENUEFurther company coverage: BXN.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL5N3ON21D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BXN.AU"],"gpt_icon":0},{"id":"2506653371","title":"Bioxyne Ltd - a$6.1 Mln Q2 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2506653371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506653371?lang=en_us&edition=fundamental","pubTime":"2025-01-28 06:20","pubTimestamp":1738016457,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3ON16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BXN.AU","BK7508"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10}]}}